BioSpace News Archive

Feb. 25, 2020 14:03 UTC Logix Smart™ COVID-19 Test CE Marked & Available in Europe Four Weeks After Project Initiation MADISON, Wis.--( BUSINESS WIRE )-- Promega Corporation is being recognized by Utah-based Co-Diagnostics, Inc. for the support Promega custom manufacturing provided in the rapid development and launch of the new Logix Smart™ COVID-19 Test. Co-Diagnostics yesterday afternoon announced its coronavirus test received CE mark approval and is now availabl

American BriVision Corporation, a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology, announced it has postponed the public offering of its Series A Convertible Preferred Stock until a more opportune time.

NeuroMetrix, Inc. (Nasdaq: NURO) today reported that it will present two scientific posters at the American Academy of Pain Medicine (AAPM) 36th Annual Meeting to be held February 26 - March 1 in National Harbor, MD.

Ambry Genetics (Ambry), a leading clinical genetic testing lab, announced the publication of a study in Nature Partner Journal Precision Oncology finding that RNA genetic testing, conducted at the same time as DNA testing, identifies more genetic mutations that increase genetic cancer risk than DNA testing alone

BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced the closing and funding of its previously announced “best efforts” underwritten offering of 2,500,000 shares of its common stock, $0.001 par value per share, at a price to the public of $4.00 per share

Gritstone Oncology (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight multiple cancer types, today announced that Andrew Allen, M.D., Ph.D., co-founder, president and chief executive officer, will present a company overview at two upcoming investor conferences in March.

AIDS Healthcare Foundation welcomed a letter signed by 46 Members of the U.S. House of Representatives asking the Trump Administration to make a potential vaccine against the coronavirus disease accessible, affordable and available..

AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation, today announced that Hamza Suria, chief executive officer of AnaptysBio, will present at the Cowen and Company 40th Annual Health Care Conference on Tuesday, March 3, 2020

MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today provided an update on its recent corporate progress and reported financial results for the year ended December 31, 2019.

Amedisys, Inc. (NASDAQ: AMED), one of America’s leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, President and Chief Executive Officer, will present at the Raymond James 41st Annual Institutional Investors Conference in Orlando, Florida on Tuesday, March 3, 2020.